Literature DB >> 25372814

Structure of type II dehydroquinase from Pseudomonas aeruginosa.

Scott Reiling1, Alan Kelleher2, Monica M Matsumoto2, Gonteria Robinson2, Oluwatoyin A Asojo2.   

Abstract

Pseudomonas aeruginosa causes opportunistic infections and is resistant to most antibiotics. Ongoing efforts to generate much-needed new antibiotics include targeting enzymes that are vital for P. aeruginosa but are absent in mammals. One such enzyme, type II dehydroquinase (DHQase), catalyzes the interconversion of 3-dehydroquinate and 3-dehydroshikimate, a necessary step in the shikimate pathway. This step is vital for the proper synthesis of phenylalanine, tryptophan, tyrosine and other aromatic metabolites. The recombinant expression, purification and crystal structure of catalytically active DHQase from P. aeruginosa (PaDHQase) are presented. Cubic crystals belonging to space group F23, with unit-cell parameters a=b=c=125.39 Å, were obtained by vapor diffusion in sitting drops and the structure was refined to an R factor of 16% at 1.74 Å resolution. PaDHQase is a prototypical type II DHQase with the classical flavodoxin-like α/β topology.

Entities:  

Keywords:  Pseudomonas aeruginosa; shikimate pathway; type II dehydroquinase

Mesh:

Substances:

Year:  2014        PMID: 25372814      PMCID: PMC4231849          DOI: 10.1107/S2053230X14020214

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  41 in total

1.  Specificity of substrate recognition by type II dehydroquinases as revealed by binding of polyanions.

Authors:  Lewis D B Evans; Aleksander W Roszak; Lorna J Noble; David A Robinson; Peter A Chalk; Jennifer L Matthews; John R Coggins; Nicholas C Price; Adrian J Lapthorn
Journal:  FEBS Lett       Date:  2002-10-23       Impact factor: 4.124

2.  Likelihood-enhanced fast rotation functions.

Authors:  Laurent C Storoni; Airlie J McCoy; Randy J Read
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-02-25

3.  Discovery of Schaeffer's acid analogues as lead structures of mycobacterium tuberculosis type II dehydroquinase using a rational drug design approach.

Authors:  Marco F Schmidt; Oliver Korb; Nigel I Howard; Marcio V B Dias; Tom L Blundell; Chris Abell
Journal:  ChemMedChem       Date:  2012-11-21       Impact factor: 3.466

4.  Nosocomial pneumonia in patients with acute respiratory distress syndrome.

Authors:  J Chastre; J L Trouillet; A Vuagnat; M L Joly-Guillou; H Clavier; M C Dombret; C Gibert
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

5.  Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover.

Authors:  Beatriz Blanco; Verónica Prado; Emilio Lence; José M Otero; Carmela Garcia-Doval; Mark J van Raaij; Antonio L Llamas-Saiz; Heather Lamb; Alastair R Hawkins; Concepción González-Bello
Journal:  J Am Chem Soc       Date:  2013-08-09       Impact factor: 15.419

Review 6.  Ventilator-associated pneumonia.

Authors:  Jean Chastre; Jean-Yves Fagon
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

7.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes.

Authors:  Geoffrey L Winsor; David K W Lam; Leanne Fleming; Raymond Lo; Matthew D Whiteside; Nancy Y Yu; Robert E W Hancock; Fiona S L Brinkman
Journal:  Nucleic Acids Res       Date:  2010-10-06       Impact factor: 16.971

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  3 in total

1.  An Evolutionary Conservation and Druggability Analysis of Enzymes Belonging to the Bacterial Shikimate Pathway.

Authors:  Rok Frlan
Journal:  Antibiotics (Basel)       Date:  2022-05-17

2.  Pathway-Centric Structure-Based Multi-Target Compound Screening for Anti-Virulence Drug Repurposing.

Authors:  Li Xie; Lei Xie
Journal:  Int J Mol Sci       Date:  2019-07-17       Impact factor: 5.923

Review 3.  Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs.

Authors:  José E S Nunes; Mario A Duque; Talita F de Freitas; Luiza Galina; Luis F S M Timmers; Cristiano V Bizarro; Pablo Machado; Luiz A Basso; Rodrigo G Ducati
Journal:  Molecules       Date:  2020-03-11       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.